Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With… — Class III food recall F-1338-2013
Terminated recall by Nexgen Pharma, Inc., reported 2013-05-01, distributed nationwide. Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsul
| Recall number | F-1338-2013 |
|---|---|
| Product type | Food |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Nexgen Pharma, Inc., Colorado Springs, CO, United States |
| Recall initiated | 2013-04-15 |
| Classified | 2013-04-19 |
| Reported by FDA | 2013-05-01 |
| Terminated | 2013-09-06 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA, NL |
| Quantity | 4,571 bottles |
| Lot numbers | 412567 |
Product
Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.
Reason for recall
Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/F-1338-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.